Genetics company 23andMe, Inc.announced it will buy telehealth and online pharmacy Lemonaid Health for $400m in cash and stock, catapulting its way into the primary care business.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?